Celestia S. Higano

Canadian Journal of Urology, Vol.12, Suppl.3, pp. 38-41, 2005

Abstract Introduction: Men with advanced prostate cancer now have many treatment options which include first and second-line hormonal therapy, chemotherapy, radiation therapy, (either directed external beam or systemic radio-isotope), and investigational agents on protocols. Additional adjunctive therapy with the bisphosphonate, zoledronic acid, to reduce skeletal complications should be considered.
Discussion: This review will discuss appropriate timing of many of these options and summarize the randomized trials demonstrating survival benefit for docetaxel and decreased skeletal morbidity for zoledronic acid.
Conclusion: The clinical trials conducted to date do not address the question of when to give chemotherapy in the course of More >

Tony Choon Seng Woo, Richard Choo, Sarat Chander

Canadian Journal of Urology, Vol.11, No.5, pp. 2390-2392, 2004

Abstract Breast and prostate cancer occurring concurrently is a rare occurrence. However, the recent literature has reported that there is an increased incidence of male breast cancer in prostate cancer patients. The authors describe the case of a man who presented with breast cancer, which was preceded by prostate cancer. There are some common features in terms of the etiology, diagnosis and treatment of these two tumors which are discussed. More >

S. Ghosh ¹

CMES-Computer Modeling in Engineering & Sciences, Vol.5, No.1, pp. 1-4, 2004, DOI:10.3970/cmes.2004.005.001

Abstract This article has no abstract. More >

Gerald B. Brock

Canadian Journal of Urology, Vol.10, Suppl.1, pp. 1-1, 2003

Abstract This article has no abstract. More >

Angelo Carini¹, Riccardo Pietrabissa²

CMES-Computer Modeling in Engineering & Sciences, Vol.4, No.3&4, pp. 345-350, 2003, DOI:10.3970/cmes.2003.004.345

Abstract This article has no abstract. More >

Joseph L. Chin, Stephen E. Pautler

Canadian Journal of Urology, Vol.9, No.4, pp. 1576-1582, 2002

Abstract The diagnostic rate of small, "incidental" tumors which are amenable to local excision or ablation has increased significantly due to widespread use of non-invasive body imaging tests. The role of nephron-sparing tumor­ablative surgery has expanded beyond the traditional circumstances of neoplasms in solitary/functionally solitary kidneys or tumors present bilaterally. Due to technologic advances, possible therapeutic options now include open surgery, laparoscopic, percutaneous and extraciorporeal approaches, in addition to surveillance in some cases. This review will concentrate on the new energy sources available for tumor ablation rather than the different surgical approaches, with a detailed review More >

Deepak Srivastava¹, Satya N. Atluri²

CMES-Computer Modeling in Engineering & Sciences, Vol.3, No.5, pp. 531-538, 2002, DOI:10.3970/cmes.2002.003.531

Abstract The current status of the progress and developments in computational nanotechnology is briefly reviewed, from the perspective of its applications. The enabling tools and techniques of physics- and chemistry-based simulations, within a multi-scale context , are briefly reviewed . More >

B. F. Romanowicz¹, M. H. Zaman¹, S. F. Bart¹, V. L. Rabinovich¹, I. Tchertkov¹, S. Zhang¹, M. G. da Silva¹, M. Deshpande¹, K. Greiner¹, J. R. Gilbert¹, Shawn Cunningham²

CMES-Computer Modeling in Engineering & Sciences, Vol.1, No.1, pp. 45-64, 2000, DOI:10.3970/cmes.2000.001.045

Abstract Development of micro-electro-mechanical systems (MEMS) products is currently hampered by the need for design aids, which can assist in integration of all domains of the design. The cross-disciplinary character of microsystems requires a top-down approach to system design which, in turn, requires designers from many areas to work together in order to understand the effects of one sub-system on another. This paper describes current research on a methodology and tool-set which directly support such an integrated design process. More >